Lab Automation Market to Reach USD 6.9 Billion by 2036 Amid Rising Adoption of AI-Driven Laboratory Workflows and High-Throughput Research Platforms

The global Lab Automation Market is poised for robust expansion, according to latest insights by future market insights. The market was valued at USD 2.5 billion in 2025 and is estimated to reach USD 2.7 billion in 2026. Over the forecast period from 2026 to 2036, the market is projected to expand at a CAGR of 9.7%, reaching approximately USD 6.9 billion by 2036. Growth is being fueled by increasing demand for high-throughput testing, rapid advances in personalized medicine, expanding pharmaceutical R&D activities, growing diagnostic workloads, and the integration of artificial intelligence into laboratory workflows.

Key Lab Automation Market Projections

• Market Size (2025): USD 2.5 Billion
• Market Size (2026): USD 2.7 Billion
• Forecast Market Value (2036): USD 6.9 Billion
• CAGR (2026-2036): 9.7%
• Leading Component Segment: Devices (65.0% Market Share)
• Leading Application Segment: Life Sciences Research and Development (38.0% Market Share)
• Fastest Growing Country: United States (10.3% CAGR)
• Second Fastest Growing Region: European Union (9.8% CAGR)
• Market Leader: Thermo Fisher Scientific, Inc.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-394

Strategic Market Insights

The lab automation industry is experiencing a major transformation as pharmaceutical companies, biotechnology firms, clinical laboratories, and research institutes increasingly adopt automated technologies to improve laboratory efficiency, accuracy, and throughput. Automated liquid handling systems, robotic sample preparation platforms, molecular diagnostic instruments, and laboratory information management systems (LIMS) are becoming critical components of modern laboratory infrastructure.

Life sciences research and development remains the largest application area, accounting for approximately 38.0% of total market demand. Pharmaceutical organizations continue to invest heavily in automated screening, compound management, assay development, and preclinical research systems to accelerate drug discovery timelines while reducing operational costs.

Additional opportunities are emerging from diagnostics, contract research organizations, and educational research laboratories. As testing volumes increase and laboratories face growing pressure to improve reproducibility and compliance, automation technologies are expected to become a strategic investment priority worldwide.

Analyst Perspective

"The lab automation market is moving toward connected, high-throughput laboratory environments that improve accuracy and research speed. Companies with reliable robotics, AI-based analytics, and flexible workflow software are likely to gain advantage as labs modernize research and diagnostics operations," said Sabyasachi Ghosh, Associate Vice President for Healthcare at FMI.

Competitive Landscape and Market Share Analysis

The global lab automation market remains highly competitive, with leading technology providers strengthening their market positions through integrated automation ecosystems, advanced software platforms, and comprehensive service networks.

Leading Market Participants Include:

• Thermo Fisher Scientific, Inc.
• Beckman Coulter (Danaher Corporation)
• Siemens Healthineers AG
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Tecan Group Ltd.
• Hamilton Company
• Labcyte Inc.
• Luminex Corporation
• BioTek Instruments
• Transcriptic (Strateos)
• Opentrons

Thermo Fisher Scientific currently maintains a leading position through its extensive laboratory automation portfolio, including liquid handling robots, microplate readers, automated sample preparation systems, and integrated workflow solutions serving pharmaceutical, research, and clinical laboratories globally.

Production vs. Consumption Economy Analysis

Production activities are concentrated across North America, Europe, Japan, South Korea, and select Asia-Pacific countries, where advanced manufacturing capabilities and strong life sciences ecosystems support the development of laboratory automation technologies.

From a consumption perspective, the United States, European Union, Japan, South Korea, China, and India represent major demand centers due to significant pharmaceutical research investments, growing biotechnology sectors, expanding clinical diagnostics networks, and increasing laboratory modernization initiatives.

Supply Chain and Value Chain Insights

The lab automation value chain begins with component manufacturing, software development, robotics engineering, and analytical instrumentation production. This is followed by system integration, software deployment, laboratory implementation, distribution, and end-user operations.

Manufacturers are increasingly focusing on integrated workflow solutions that combine automation hardware with cloud-based software platforms, enabling laboratories to streamline data management, compliance monitoring, and workflow optimization. Strategic partnerships between instrument manufacturers and software providers continue to strengthen supply chain efficiency.

Strategic Procurement Analysis

Procurement priorities are evolving beyond hardware performance alone. Buyers increasingly evaluate laboratory automation platforms based on software interoperability, scalability, AI integration capabilities, regulatory compliance, cybersecurity standards, and compatibility with existing laboratory infrastructure.

Organizations are also emphasizing long-term service agreements, predictive maintenance capabilities, and vendor support programs to maximize system utilization and operational continuity.

Customize insights for your business strategy@ https://www.futuremarketinsights.com/customization-available/rep-gb-394

Country Opportunity Assessment

The United States is expected to remain the fastest-growing major market, expanding at a CAGR of 10.3% through 2036. Growth is supported by pharmaceutical R&D investments, clinical laboratory consolidation, and rapid adoption of AI-enabled laboratory technologies.

The European Union follows closely with a CAGR of 9.8%, driven by centralized laboratory modernization programs, pharmaceutical manufacturing automation, and government-funded research initiatives.

South Korea and Japan are projected to generate significant opportunities due to biotechnology sector growth, increasing diagnostic testing requirements, and government investments in life sciences infrastructure.

Technology and Innovation Outlook

Key innovations shaping the industry include:
• AI-powered laboratory intelligence platforms
• Robotic liquid handling systems
• Automated sample preparation technologies
• Cloud-connected laboratory management systems
• Predictive maintenance and remote monitoring solutions
• Integrated laboratory information management systems (LIMS)
• High-throughput screening automation
• Modular and scalable laboratory robotics platforms
Manufacturers are increasingly investing in intelligent automation ecosystems capable of reducing human intervention while improving laboratory productivity, data integrity, and operational efficiency.

Future Industry Outlook

The Lab Automation Market is expected to benefit from growing pharmaceutical research investments, expanding clinical diagnostics requirements, and increasing demand for precision medicine. The convergence of robotics, artificial intelligence, advanced analytics, and laboratory informatics is anticipated to accelerate automation adoption across pharmaceutical, clinical, and academic laboratories.

Companies capable of delivering integrated, scalable, and AI-enabled automation solutions are expected to capture substantial growth opportunities through 2036 as laboratories worldwide continue their transition toward fully connected and digitally enabled operating environments.

Purchase Full Report for Detailed Insights: https://www.futuremarketinsights.com/reports/lab-automation-market

Why Choose FMI: https://www.futuremarketinsights.com/why-fmi

Explore More Related Studies Published by FMI Research:

Femtech Market https://www.futuremarketinsights.com/reports/femtech-market

Dental Sutures Market https://www.futuremarketinsights.com/reports/dental-sutures-market

Radiation Toxicity Treatment Market https://www.futuremarketinsights.com/reports/radiation-toxicity-treatment-market

Explore In-Depth Healthcare Market Insights: https://www.futuremarketinsights.com/industry-analysis/healthcare

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization trusted by global enterprises and Fortune 500 companies. FMI delivers actionable market intelligence, competitive benchmarking, and strategic insights across more than 30 industries and 1,200 markets worldwide.

This release was published on openPR.